Patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use GLP-1 medications
MH-S cells were stimulated with different concentrations of silica particles
"Some studies have shown there have been concerns with mislabeling, contamination, inconsistent dosing, meaning consumers may not even know what they're taking," Widmer said
*Correspondence: Yaqi Zeng [email protected] These authors have contributed equally to this work ORCID: Zhehong Shen orcid.org/0009-0002-0978-9127 Xiaotian Liu orcid.org/0009-0002-6508-720X Jun Meng orcid.org/0009-0004-4211-0870 Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
real-world data in older adults with T2DM reported no clear excess risk compared to other antidiabetic agents
Nishimura, Y., Kanda, Y., Sone, H., & Aoyama, H
